Skip to main content
Livermore
Livermore
ZHEN

FibroBiologics, Inc.

FBLG
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001958777

No open-market purchases or sales by FibroBiologics, Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $269.6K in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding FibroBiologics, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of FBLG: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders1750+33
Shares480.4K3.44M+2.96M (+616.1%)
Value$5.18M$17.2M+$12.0M (+231.4%)

New holders (39)

Institutions that held FibroBiologics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to FBLG in Q2 2024
InstitutionSharesValue% of portfolio
State Street Corp376,048$1.88M0.00%
Cascade Financial Partners, LLC315,055$1.57M0.21%
Vanguard Group Inc221,194$1.10M0.00%
Transform Wealth, LLC133,890$668.1K0.05%
Optivise Advisory Services LLC110,100$549.4K0.30%
Requisite Capital Management, LLC109,713$547.5K0.12%
American Institute for Advanced Investment Management, LLP88,206$440.1K0.34%
Bank of America Corp80,545$401.9K0.00%
Bank of New York Mellon Corp68,558$342.1K0.00%
Charles Schwab Investment Management Inc66,281$330.7K0.00%
Advisor Group Holdings, Inc.52,903$264.0K0.00%
RMR Wealth Builders37,360$186.4K0.02%
Concurrent Investment Advisors, LLC35,283$176.1K0.01%
Nuveen Asset Management, LLC34,540$172.4K0.00%
ERn Financial, LLC31,819$158.8K0.03%
Ethos Financial Group, LLC25,455$127.0K0.02%
Alpine Global Management, LLC24,092$120.2K0.02%
Morgan Stanley23,476$117.1K0.00%
Rhumbline Advisers23,057$115.0K0.00%
New York State Common Retirement Fund21,500$107.3K0.00%
Saxon Interests, Inc.21,214$105.9K0.05%
Raymond James & Associates17,642$88.0K0.00%
Perigon Wealth Management, LLC16,906$84.4K0.00%
Cahaba Wealth Management, Inc.14,702$73.4K0.01%
Corebridge Financial, Inc.13,690$68.5K0.00%
Goldman Sachs Group Inc12,821$64.0K0.00%
Invesco Ltd.12,280$61.3K0.00%
Mercer Global Advisors Inc10,272$51.3K0.00%
Envestnet Asset Management Inc10,272$51.3K0.00%
Barclays PLC8,627$43.0K0.00%
STRS Ohio4,700$23.5K0.00%
Legal & General Group Plc2,816$14.1K0.00%
Ameritas Investment Partners, Inc.2,493$12.4K0.00%
California State Teachers Retirement System1,844$9.20K0.00%
BNP Paribas Arbitrage, SA1,800$8.98K0.00%
Grove Bank & Trust1,000$4.99K0.00%
Amalgamated Bank880$4.00K0.00%
Deutsche Bank AG679$3.39K0.00%
Northwestern Mutual Wealth Management Co74$3690.00%

Sold out (6)

Institutions that held FibroBiologics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of FBLG in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
HRT Financial LP57,344$619.0K
ExodusPoint Capital Management, LP25,591$277.0K
Point72 (DIFC) Ltd15,915$172.0K
Balyasny Asset Management LLC14,246$154.0K
Cubist Systematic Strategies, LLC8,978$97.1K
Macquarie Group Ltd1,073$12